BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36383412)

  • 1. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
    EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function
    Huang FW; Mosquera JM; Garofalo A; Oh C; Baco M; Amin-Mansour A; Rabasha B; Bahl S; Mullane SA; Robinson BD; Aldubayan S; Khani F; Karir B; Kim E; Chimene-Weiss J; Hofree M; Romanel A; Osborne JR; Kim JW; Azabdaftari G; Woloszynska-Read A; Sfanos K; De Marzo AM; Demichelis F; Gabriel S; Van Allen EM; Mesirov J; Tamayo P; Rubin MA; Powell IJ; Garraway LA
    Cancer Discov; 2017 Sep; 7(9):973-983. PubMed ID: 28515055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent gene fusions in prostate cancer.
    Kumar-Sinha C; Tomlins SA; Chinnaiyan AM
    Nat Rev Cancer; 2008 Jul; 8(7):497-511. PubMed ID: 18563191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIC is a critical regulator of neuronal differentiation.
    Hwang I; Pan H; Yao J; Elemento O; Zheng H; Paik J
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32229723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Erf-Mediated Craniosynostosis and Pharmacological Amelioration.
    Vogiatzi A; Keklikoglou K; Makris K; Argyrou DS; Zacharopoulos A; Sotiropoulou V; Parthenios N; Gkikas A; Kokkori M; Richardson MSW; Fenwick AL; Archontidi S; Arvanitidis C; Robertson J; Parthenios J; Zacharakis G; Twigg SRF; Wilkie AOM; Mavrothalassitis G
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
    Kim TD; Gu R; Janknecht R
    Int J Biochem Mol Biol; 2023; 14(6):101-115. PubMed ID: 38213775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity.
    Takemon Y; LeBlanc VG; Song J; Chan SY; Lee SD; Trinh DL; Ahmad ST; Brothers WR; Corbett RD; Gagliardi A; Moradian A; Cairncross JG; Yip S; Aparicio SAJR; Chan JA; Hughes CS; Morin GB; Gorski SM; Chittaranjan S; Marra MA
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345142
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.
    Schafer C; Young D; Singh H; Jayakrishnan R; Banerjee S; Song Y; Dobi A; Petrovics G; Srivastava S; Srivastava S; Sesterhenn IA; Chesnut GT; Tan SH
    J Immunol Methods; 2023 Jul; 518():113493. PubMed ID: 37196930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic ETS Factors in Prostate Cancer.
    Nicholas TR; Strittmatter BG; Hollenhorst PC
    Adv Exp Med Biol; 2019; 1210():409-436. PubMed ID: 31900919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteins of the ETS family with transcriptional repressor activity.
    Mavrothalassitis G; Ghysdael J
    Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The
    Gupta N; Song H; Wu W; Ponce RK; Lin YK; Kim JW; Small EJ; Feng FY; Huang FW; Okimoto RA
    Elife; 2022 Nov; 11():. PubMed ID: 36383412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
    Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
    Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of
    Singh R; Cohen ASA; Poulton C; Hjortshøj TD; Akahira-Azuma M; Mendiratta G; Khan WA; Azmanov DN; Woodward KJ; Kirchhoff M; Shi L; Edelmann L; Baynam G; Scott SA; Jabs EW
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117072
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.